In solid cancers, especially in NSCLC, YAP/TAZ are not only upregulated by Hippo signaling, but also by other molecular mechanisms (Lu et al., 2018; Ma et al., 2020; Pocaterra et al., 2020). This evidence concerns the gene YAP1 and non-small cell lung carcinoma.